| abstract |
The present invention relates to 4- [5-methyl-6- (2-methylpyridin-3-yloxy) pyrimidin-4-yloxy] piperidine-1-carboxylic acid isopropyl ester, its pharmaceutically acceptable salts, solvates and hydrates, which are modulators of metabolism glucose. Accordingly, the compounds of the present invention are useful in the treatment of metabolic-related disorders and, as a consequence, complications such as diabetes and obesity. |